SYK / Q3 2026 (FQ3 2026 - Sep 2026; quarter ended 2026-09-30; fiscal year = calendar year)

Stryker Corporation

Reported: Oct 29, 2026

Forecast published

Oct 27, 2026 at 10:11 PM PDT

Opus 5.5 High in Shortcut

Shortcut

3.57

Normalized diluted EPS

+0.6% vs Street

Off by $0.05 per share

Street

3.55

Normalized diluted EPS

October 25 consensus snapshot

Off by $0.03 per share

Real

3.52

Stryker issuer adjusted diluted EPS

Street win

Reported result · Oct 29 ↗ · The issuer quarterly reconciliation reports adjusted diluted EPS 3.52 versus reported 1.96 and adjusted net earnings 1357m.

USD per diluted common share. Comparisons use unrounded estimates.

Model download

Explore the assumptions and calculations behind the forecast.

Open in Shortcut ↗Download XLSX ↓

Shortcut’s reasoning.

Bottom-up revenue $6,600.5m (+9.0% reported, ~9.2% organic, FX -0.2%): capital catch-up after the March cyberattack lifts Medical/Endoscopy, offset by the Inari peripheral-vascular supply constraint (~70-80bp drag, CFO 8-Sep) and soft hips/knees in Jul/Aug; slightly below consensus $6,617.1m.

Adjusted operating margin 26.3% (+70bp y/y): adj. GM 65.4%, R&D 6.6%, SG&A 32.5% ; tariff relief and leverage offset by cyber remediation/lost absorption and mix; consistent with FY26 adj. EPS guide $14.95-15.10 reaffirmed 30-Jul and not withdrawn on 8-Sep.

Below the line: adj. other expense $(111)m (FY ~$420m guide), adj. tax rate 15.3% (FY 15-16% guide), diluted shares 385.4m after an assumed $500m 3Q buyback (resumption announced 30-Jul).

On the record.

Reporting period: Q3 2026 (FQ3 2026 - Sep 2026; quarter ended 2026-09-30; fiscal year = calendar year)
Reporting basis: Adjusted (non-GAAP) net earnings per diluted common share, USD = consensus normalized diluted EPS basis
Consensus snapshot: October 25, 2026
Model / effort: Opus 5.5 · High effort
Workbook: Reviewed workbook

Record history

Forecast generated: Oct 27, 2026 at 5:30 PM PDT
Original author completed: Oct 27, 2026 at 4:32 PM PDT
Reviewed revision completed: Oct 27, 2026 at 5:30 PM PDT
First published: Oct 27, 2026 at 10:11 PM PDT

Result basis

The issuer quarterly reconciliation reports adjusted diluted EPS 3.52 versus reported 1.96 and adjusted net earnings 1357m. Scoring retains the published issuer-adjusted diluted common-share USD basis. The source Q32025adjusted comparative 3.19 matches frozenhistory. The corresponding prior-year fiscal-quarter issuer adjusted comparative 3.19 matches the frozen normalized history. This does not certify exhaustive item-level vendor equivalence.